Critical Analysis: Nexeon Medsystems (NXNND) & Its Rivals

Nexeon Medsystems (OTCMKTS: NXNND) is one of 47 public companies in the “Electromedical equipment” industry, but how does it weigh in compared to its peers? We will compare Nexeon Medsystems to similar businesses based on the strength of its risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.

Institutional and Insider Ownership

43.7% of shares of all “Electromedical equipment” companies are held by institutional investors. 61.2% of Nexeon Medsystems shares are held by company insiders. Comparatively, 15.5% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.



Profitability

This table compares Nexeon Medsystems and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nexeon Medsystems N/A N/A N/A
Nexeon Medsystems Competitors -126.11% -67.73% -20.10%

Analyst Ratings

This is a breakdown of recent ratings and target prices for Nexeon Medsystems and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nexeon Medsystems 0 0 0 0 N/A
Nexeon Medsystems Competitors 186 536 1110 45 2.54

As a group, “Electromedical equipment” companies have a potential upside of 16.89%. Given Nexeon Medsystems’ peers higher probable upside, analysts clearly believe Nexeon Medsystems has less favorable growth aspects than its peers.

Valuation & Earnings

This table compares Nexeon Medsystems and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Nexeon Medsystems $3.30 million -$2.17 million -2.61
Nexeon Medsystems Competitors $1.16 billion $92.96 million -33.12

Nexeon Medsystems’ peers have higher revenue and earnings than Nexeon Medsystems. Nexeon Medsystems is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

Nexeon Medsystems beats its peers on 5 of the 9 factors compared.

Nexeon Medsystems Company Profile

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

Receive News & Ratings for Nexeon Medsystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexeon Medsystems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply